A detailed history of Equitable Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Equitable Trust CO holds 1,991 shares of NVS stock, worth $193,405. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,991
Holding current value
$193,405
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$106.13 - $120.89 $211,304 - $240,691
1,991 New
1,991 $229,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Equitable Trust CO Portfolio

Follow Equitable Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.